cisatracurium besylate (Sandoz Inc)
Welcome to the PulseAid listing for the cisatracurium besylate drug offered from Sandoz Inc. This Neuromuscular Nondepolarizing Blockade [PE],Nondepolarizing Neuromuscular Blocker [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Sandoz Inc |
NON-PROPRIETARY NAME: | cisatracurium besylate |
SUBSTANCE NAME: | CISATRACURIUM BESYLATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Neuromuscular Nondepolarizing Blockade [PE],Nondepolarizing Neuromuscular Blocker [EPC] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2012-07-16 |
END MARKETING DATE: | 0000-00-00 |
cisatracurium besylate HUMAN PRESCRIPTION DRUG Details:
Item Description | cisatracurium besylate from Sandoz Inc |
LABELER NAME: | Sandoz Inc |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 2(mg/mL) |
START MARKETING DATE: | 2012-07-16 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0781-3150_efc2e2c8-9024-4a81-a974-ec08b7de7663 |
PRODUCT NDC: | 0781-3150 |
APPLICATION NUMBER: | ANDA200154 |
Other CISATRACURIUM BESYLATE Pharmaceutical Manufacturers / Labelers: